Münk Carsten, Zielonka Jörg, Constabel Hannelore, Kloke Björn-Philipp, Rengstl Benjamin, Battenberg Marion, Bonci Francesca, Pistello Mauro, Löchelt Martin, Cichutek Klaus
Division of Medical Biotechnology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225 Langen, Germany.
J Virol. 2007 Jul;81(13):7048-60. doi: 10.1128/JVI.02714-06. Epub 2007 Apr 25.
The productive replication of human immunodeficiency virus type 1 (HIV-1) occurs exclusively in defined cells of human or chimpanzee origin, explaining why heterologous animal models for HIV replication, pathogenesis, vaccination, and therapy are not available. This lack of an animal model for HIV-1 studies prompted us to examine the susceptibility of feline cells in order to evaluate the cat (Felis catus) as an animal model for studying HIV-1. Here, we report that feline cell lines harbor multiple restrictions with respect to HIV-1 replication. The feline CD4 receptor does not permit virus infection. Feline T-cell lines MYA-1 and FeT-1C showed postentry restrictions resulting in low HIV-1 luciferase reporter activity and low expression of viral Gag-Pol proteins when pseudotyped vectors were used. Feline fibroblastic CrFK and KE-R cells, expressing human CD4 and CCR5, were very permissive for viral entry and HIV-long terminal repeat-driven expression but failed to support spreading infection. KE-R cells displayed a profound block with respect to release of HIV-1 particles. In contrast, CrFK cells allowed very efficient particle production; however, the CrFK cell-derived HIV-1 particles had low specific infectivity. We subsequently identified feline apolipoprotein B-editing catalytic polypeptide 3 (feAPOBEC3) proteins as active inhibitors of HIV-1 particle infectivity. CrFK cells express at least three different APOBEC3s: APOBEC3C, APOBEC3H, and APOBEC3CH. While the feAPOBEC3C did not significantly inhibit HIV-1, the feAPOBEC3H and feAPOBEC3CH induced G to A hypermutations of the viral cDNA and reduced the infectivity approximately 10- to approximately 40-fold.
1型人类免疫缺陷病毒(HIV-1)的有效复制仅发生在人类或黑猩猩来源的特定细胞中,这就解释了为何不存在用于HIV复制、发病机制、疫苗接种及治疗的异源动物模型。缺乏用于HIV-1研究的动物模型促使我们检测猫科动物细胞的易感性,以便评估猫(家猫)作为研究HIV-1的动物模型。在此,我们报告猫科动物细胞系对HIV-1复制存在多种限制。猫科动物CD4受体不允许病毒感染。当使用假型载体时,猫科动物T细胞系MYA-1和FeT-1C表现出感染后限制,导致HIV-1荧光素酶报告基因活性较低,病毒Gag-Pol蛋白表达水平也较低。表达人类CD4和CCR5的猫科动物成纤维细胞CrFK和KE-R细胞对病毒进入和HIV长末端重复序列驱动的表达非常敏感,但无法支持病毒的传播感染。KE-R细胞在HIV-1颗粒释放方面存在严重障碍。相比之下,CrFK细胞允许高效产生颗粒;然而,CrFK细胞衍生的HIV-1颗粒的特异性感染性较低。我们随后鉴定出猫科动物载脂蛋白B编辑催化多肽3(feAPOBEC3)蛋白是HIV-1颗粒感染性的活性抑制剂。CrFK细胞表达至少三种不同的APOBEC3:APOBEC3C、APOBEC3H和APOBEC3CH。虽然feAPOBEC3C对HIV-1的抑制作用不显著,但feAPOBEC3H和feAPOBEC3CH诱导病毒cDNA发生G到A的超突变,并使感染性降低约10至约40倍。